Amy Lynn Ronneberg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amy Lynn Ronneberg
Earlier roles on record: Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) until September 11, 2023. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Amy Lynn Ronneberg resigned as Board of Directors, effective September 11, 2023.
“In accordance with the Merger Agreement, immediately prior to and effective upon the closing of the Merger, Jeffrey W. Albers, Bruce Booth, D. Phil., Thomas O. Daniel, M.D., Amy Lynn Ronneberg, David T. Scadden, M.D. and Michael Vasconcelles, M.D. resigned from the Board of Directors and committees of the Board of Directors on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-09-11
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.